The Vigabatrin REMS Program is needed by the FDA to ensure educated risk-benefit choices before launching treatment, and to guarantee proper use vigabatrin while patients are dealt with. It is not possible for your doctor to recognize when vision loss will certainly happen.
The most typical adverse effects of SABRIL in children 3 to 16 years is weight gain. With extreme vision loss, you might only have the ability to see points straight in front of you (in some cases called tunnel vision"). You are at risk for vision loss with any amount of SABRIL.
Tell your healthcare provider if you are pregnant or intend to get pregnant. If vision testing can not be done, your healthcare provider may continue suggesting SABRIL, but will not have the ability to look for any type of vision loss. If vision examinations are refrained frequently, your healthcare provider may quit suggesting SABRIL for you (or your child).